Speaker List
Inventors. Regulatory officials and experts. High level researchers. Program heads. The bios of our speakers and presenters are impressive to say the least. These are the brains you can't wait to pick. Find a full list of confirmed speakers in myBIO.
-
Shahrooz Nabavi
Partner, Fasken Martineau DuMoulin LLPSession:
Canadian Financial Incentives Spur Research and Development
International Market Briefings Track -
Cyra Nargolwalla
Partner , Cabinet PlasseraudSession:
The Unitary Patent: How Will it Affect the Biotech Sector and Your Business?
Biotech Patenting and Tech Transfer Track -
Ken Narva
Research Fellow, Dow Agrosciences LLCSession:
Epigenetics: More than a Mere Expression
Food and Agriculture Track -
Nina Nashif
Managing Director , Sandbox Industries -
Carl Nathan, MD
Professor Microbiology and Immunology and Medicine, Weill Cornell Medical College -
Alexander Natz
Director General, EUCOPESession:
The Unitary Patent: How Will it Affect the Biotech Sector and Your Business?
Biotech Patenting and Tech Transfer Track -
Alexander Natz
Director General, EUCOPESession:
The Unitary Patent: How Will it Affect the Biotech Sector and Your Business?
Biotech Patenting and Tech Transfer Track -
Garry Neil, MD
Partner & Head of R & D, Apple Tree PartnersSession:
Innovative Innovation: New Partners, New Partnerships
Super Sessions -
Eric Nelson
Business Development Consultant, National Institutes of Health, NINDSSession:
Using NIH Resources to Help Advance Biomedical Technology and Drug Projects to Industry Adoption
Business Development Track -
C. David Nicholson
Global Head R&D, Bayer CropScience AGSession:
Corporate Venture Capital in the AgTech Entrepreneurial Ecosystem
Food and Agriculture Track -
Amber Niebauer
AgBiotech Program and Resource Development Manager, NC Biotechnology Center -
Matthew Nielsen
Partner, Marshall, Gerstein & Borun LLPSession:
Multi-Party and Cross-Border Patent Issues Affecting Biotech Businesses
Biotech Patenting and Tech Transfer Track -
Jeremiah (Jay) Nixon
Governor, MissouriSession:
State Legislative Best Practices in Support of Bioscience Economic Development
Special Programs -
Victor Nizet
Professor of Pediatrics and Pharmacy , University of California, San DiegoSession:
New Defenses Against Old Enemies: Vaccines and Biotherapies for Bacterial Infection
Innovations and Opportunities in Vaccines -
Oleg Nodelman
Founder and Managing Director, EcoR1 CapitalSession:
Survival Strategies for Companies Under $100M Market Cap: Routes to Equity and Exits for Micro-Cap Companies
Finance Track -
Mark Noguchi
Global Head, Alliance and Asset Management, Roche PartneringSession:
Across the Great Divide: Creating and Managing Cross-Cultural Partnerships
Business Development Track -
David Noll
Director, Governmental Affairs, Bavarian Nordic A/SSession:
Medical Countermeasures: Partnering with the FDA for Successful Product Development
Achieving Regulatory Approval and Compliance Track -
Noharuddin Nordin
Datuk, Malaysian Investment Development AuthoritySession:
Spotlight on Malaysia: BioMedical (Biopharma) Hub for the Emerging Markets
International Market Briefings Track -
Noharuddin Nordin
Datuk, Malaysian Investment Development AuthoritySession:
Spotlight on Malaysia: BioMedical (Biopharma) Hub for the Emerging Markets
International Market Briefings Track -
Derek Norman
Investment Director, Syngenta VenturesSession:
Corporate Venture Capital in the AgTech Entrepreneurial Ecosystem
Food and Agriculture Track -
Nesa Nourmohammadi
Staff Writer , FierceVaccines -
Robert Nowinski
Chief Executive Officer, Contrafect Corporation -
Rita Numerof
President, Numerof & Associates, Inc.Session:
Massive Health Care Consolidation and Its Impact on Biotech
Market Access and Commercialization Track -
Jeffrey Nye, MD, PhD
Vice President, Neuroscience Innovation and Scientific Partnership Strategy, Janssen Research and Development, LLCSession:
Demystifying Alzheimer’s Disease
Alzheimer's Forum